Unknown

Dataset Information

0

A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.


ABSTRACT: Epidermal homeostasis relies on a well-defined transcriptional control of keratinocyte proliferation and differentiation, which is critical to prevent skin diseases such as atopic dermatitis, psoriasis or cancer. We have recently shown that the homeobox transcription factor DLX3 and the tumor suppressor p53 co-regulate cell cycle-related signaling and that this mechanism is functionally involved in cutaneous squamous cell carcinoma development. Here we show that DLX3 expression and its downstream signaling depend on protein kinase C ? (PKC?) activity in skin. We found that following 12-O-tetradecanoyl-phorbol-13-acetate (TPA) topical treatment, DLX3 expression is significantly upregulated in the epidermis and keratinocytes from mice overexpressing PKC? by transgenic targeting (K5-PKC?), resulting in cell cycle block and terminal differentiation. Epidermis lacking DLX3 (DLX3cKO), which is linked to the development of a DLX3-dependent epidermal hyperplasia with hyperkeratosis and dermal leukocyte recruitment, displays enhanced PKC? activation, suggesting a feedback regulation of DLX3 and PKC?. Of particular significance, transcriptional activation of epidermal barrier, antimicrobial peptide and cytokine genes is significantly increased in DLX3cKO skin and further increased by TPA-dependent PKC activation. Furthermore, when inhibiting PKC activity, we show that epidermal thickness, keratinocyte proliferation and inflammatory cell infiltration are reduced and the PKC-DLX3-dependent gene expression signature is normalized. Independently of PKC, DLX3 expression specifically modulates regulatory networks such as Wnt signaling, phosphatase activity and cell adhesion. Chromatin immunoprecipitation sequencing analysis of primary suprabasal keratinocytes showed binding of DLX3 to the proximal promoter regions of genes associated with cell cycle regulation, and of structural proteins and transcription factors involved in epidermal differentiation. These results indicate that Dlx3 potentially regulates a set of crucial genes necessary during the epidermal differentiation process. Altogether, we demonstrate the existence of a robust DLX3-PKC? signaling pathway in keratinocytes that is crucial to epidermal differentiation control and cutaneous homeostasis.

SUBMITTER: Palazzo E 

PROVIDER: S-EPMC5384032 | biostudies-literature | 2017 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

A novel DLX3-PKC integrated signaling network drives keratinocyte differentiation.

Palazzo Elisabetta E   Kellett Meghan D MD   Cataisson Christophe C   Bible Paul W PW   Bhattacharya Shreya S   Sun Hong-Wei HW   Gormley Anna C AC   Yuspa Stuart H SH   Morasso Maria I MI  

Cell death and differentiation 20170210 4


Epidermal homeostasis relies on a well-defined transcriptional control of keratinocyte proliferation and differentiation, which is critical to prevent skin diseases such as atopic dermatitis, psoriasis or cancer. We have recently shown that the homeobox transcription factor DLX3 and the tumor suppressor p53 co-regulate cell cycle-related signaling and that this mechanism is functionally involved in cutaneous squamous cell carcinoma development. Here we show that DLX3 expression and its downstrea  ...[more]

Similar Datasets

| S-EPMC5948219 | biostudies-literature
2017-02-09 | GSE67714 | GEO
| S-EPMC3000738 | biostudies-literature
| PRJNA280744 | ENA
| S-EPMC5004862 | biostudies-literature
| S-EPMC2662218 | biostudies-literature
| S-EPMC6795383 | biostudies-literature
| S-EPMC4803640 | biostudies-literature
| S-EPMC5507280 | biostudies-literature
| S-EPMC9074878 | biostudies-literature